Blood Management for Hip Reconstruction Surgery

Orthopedic Clinics of North America

Volumn 40, Issue 3, 2009, Pages 417-425

  Lane, Alan ^a   Crosby, Edward T ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Blood conservation; Hip reconstruction; Transfusion

Indexed keywords

AMINOCAPROIC ACID; APROTININ; ERYTHROPOIETIN; FERROUS SULFATE; HEMOGLOBIN; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TRANEXAMIC ACID;

ANEMIA; ANESTHESIA; BLOOD AUTOTRANSFUSION; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FUNCTIONAL STATUS; HEMATOCRIT; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HIP SURGERY; HUMAN; HYPOTHERMIA; INFECTION RISK; IRON THERAPY; KNEE ARTHROPLASTY; OPERATION DURATION; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REHABILITATION CARE; REPEATED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS;

ALGORITHMS; ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HUMANS;

EID: 67649406191     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2009.02.003     Document Type: Review

References (44)

1. Finucane M.L., Slovic P., and Mertz C.K. Public perception of the risk of blood transfusion. Transfusion 40 (2000) 1017-1022
2. Stramer S.L. Current risks of transfusion transmitted agents. Arch Pathol Lab Med 131 (2007) 702-707
3. Eder A.F., and Chambers L.A. Noninfectious complications of a blood transfusion. Arch Pathol Lab Med 131 (2007) 708-718
4. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999) 2-10
5. Rashiq S., Shah M., Chow A.K., et al. Predicting allogeneic blood transfusion use in total joint arthroplasty. Anesth Analg 99 (2004) 1239-1244
6. Nuttal G.A., Santrach P.J., Oliver Jr. W.C., et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 36 (1996) 144-149
7. Rosencher N., Kerkkamp H.E., Macheras G., et al. The Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: lead management in elective knee and hip arthroplasty in Europe. Transfusion 43 (2003) 459-469
8. Nelson C.L., and Stewart J.G. Primary and revision total hip replacement in patients who are Jehovah's Witnesses. Clin Orthop 369 (1999) 251-261
9. Dunne J.R., Malone D., Tracy J.K., et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102 (2002) 237-244
10. Halm E.A., Wang J.J., Boockvar K., et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma 18 (2004) 369-374
11. Wu W.C., Schifftner T.L., Henderson W.G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 (2007) 2481-2488
12. Spence R.K. Medical and economic impact of anemia in hospitalized patients. Am J Health Syst Pharm 64 (2007) S3-S10
13. French G.W., Lam W.H., Rashid Z., et al. Perioperative silent myocardial ischemia in patients undergoing lower limb joint replacement surgery: an indicator of postoperative morbidity or mortality?. Anaesthesia 54 (1999) 235-240
14. Grover M., Talwalkar S., Casbard A., et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb of arthroplasty. Vox Sang 90 (2006) 105-112
15. Carson J.L., Noveck H., Berlin J.A., et al. Mortality and morbidity in patients with very low postoperative hemoglobin levels who declined blood transfusion. Transfusion 42 (2002) 812-818
16. Lawrence V.A., Silverstein J.H., Cornell J.E., et al. Higher hemoglobin level is associated with better early functional recovery after hip fracture repair. Transfusion 43 (2003) 1717-1722
17. Diamond P.T., Conaway M.R., Mody S.H., et al. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee arthroplasty. J Arthroplasty 21 (2006) 636-641
18. Wallis J.P., Wells A.W., Whitehead S., et al. Recovery from postoperative anemia. Transfus Med 15 (2005) 413-418
19. Diamond P.T., and Julian D.M. Practice trends in the management of low hematocrit in the acute rehabilitation setting. Am J Phys Med Rehabil 8 11 (2001) 816-820
20. Muller U., Exadaktylos A., Roeder C., et al. Effect of a flowchart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study. Br Med J 328 (2004) 934-938
21. Marinez V., Monsaingeon-Lion A., Cherif K., et al. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 99 (2007) 794-800
22. Wong C.J., Vandervoort M.K., Vandervoort S.L., et al. A cluster randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 47 (2007) 832-841
23. Robinson C.M., Christie J., and Malcolm-Smith N. Non steroidal anti inflammatory drugs, perioperative blood loss, transfusion requirements in elective hip surgery. J Arthroplasty 8 (1993) 607-610
24. Rashiq S., and Finegan B. The effect of spinal anesthesia on blood transfusion rate in total joint arthroplasty. Can J Surg 49 6 (2006) 391-396
25. Rodgers A., Walker N., Shug S., et al. Reduction of postoperative mortality and morbidity with epidural and spinal anaesthesia: results from overview of randomized trials. BMJ 321 7275 (2000) 1493
26. Sharrock N.E., and Salvati E.A. Hypotensive epidural anesthesia for total hip arthroplasty. Acta Orthop Scand 67 (1996) 17-25
27. Rajagopalan S., Mascha E., Na J., et al. The effects of mild perioperative hypothermia on blood loss and transfusion requirements. Anesthesiology 108 (2008) 71-77
28. Cushner F.D., Hawes T., Kessler D., et al. Orthopaedic-induced anemia; the fallacy of autologous donation programs. Clin Orthop Rel Res 431 (2005) 145-149
29. Laupacis A., and Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 8 (1998) 309-317
30. Sans T., Joven J., Vilella E., et al. Pharmacokinetics of several subcutaneous doses of erythropoietin: implications for blood transfusion. Clin Exp Pharmacol Physiol 27 (2000) 179-184
31. de Andrade J.R., Frei D., and Guilfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics 22 1 Suppl (1999) S113-S118
32. Canadian Orthopaedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341 (1993) 1227-1232
33. Saleh E., McClelland D.B., Hay A., et al. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 99 6 (2007) 801-807
34. Beris P., Munoz M., Garcia-Erce J.A., et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 100 5 (2008) 599-604
35. Henry D.A., Carless P.A., Moxey A.J., et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4 (2007) CD001886
36. Levy J.H. Pharmacological methods to reduce perioperative bleeding. Transfusion 48 (2008) 31S-38S
37. Zuffery P., Marquiol F., Laporte S., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology 105 (2006) 1034-1046
38. Napier J.A., Bruce M., Chapman J., et al. Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. Br J Anaesth 78 (1997) 768-771
39. Brecher M.E., and Rosenfield M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 34 (1994) 176-179
40. Segal J., Blasco-Colmenares E., Norris E., et al. Preoperative acute normovolemic hemodilution; a meta-analysis. Transfusion 44 5 (2004) 1097-1103
41. Bennet J., Haynes S., Torella F., et al. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion 46 (2006) 1097-1103
42. Goodnough L., Despotis G., Merkel K., et al. A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty. Transfusion 40 (2000) 1054-1057
43. Bridgens J.P., Evans C.R., Dobson P.M., et al. Intraoperative red blood cell salvage in revision hip surgery. A case matched study. J Bone Joint Surg Am 89 2 (2007) 270-275
44. Philips S.J., Chavan R., Porter M.L., et al. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery?. J Bone Joint Surg Br 88-B (2006) 1141-1142